Immunomedics Price Target Raised To $55 From $41 At Wells Fargo

Wells Fargo analyst Jim Birchenough raised the firm's price target on Immunomedics to $55 from $41.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.